Sara Calderón
CLINICAL RESEARCH FELLOW
Sara Calderón-Larrañaga is an academic general practitioner and health systems researcher with interests in primary health care organisation, workforce policy and comparative health systems research. She combines academic work with clinical practice as a General Practitioner in London. She holds a Master’s degree in Primary Care Research from the Autonomous University of Barcelona (2018) and a PhD in Primary Care and Public Health from Queen Mary University of London (2023).
Sara holds a part-time position at the Nuffield Department of Primary Care Health Sciences, University of Oxford, where she leads comparative international research on primary health care workforce policy and models of care in socioeconomically deprived and underserved populations, supported by an NIHR Senior Practitioner and Clinician Research Award. Alongside this role, she is a Postdoctoral Clinical Fellow at the School of Public Health, Imperial College London, where she contributes to the scientific work of the Lancet NUS-PRIME Commission (Pandemic Readiness through Institutions Mobilising Communities and Equity).
Her previous research, funded by the ESRC and NIHR, has examined community-oriented approaches to improving health and access to care in underserved populations, including the implementation and impact of social prescribing. She has worked as a consultant for the Pan American Health Organization (PAHO/WHO), advised the Spanish Ministry of Health on primary health care workforce policy, and maintains collaborations with the WHO Collaborating Centre for Quality and Equity in Primary Health Care Systems at Amsterdam UMC and the WHO European Centre for Primary Health Care.
Sara’s research is concerned with how health systems can deliver accessible, equitable and sustainable primary health care, particularly in communities facing social and economic disadvantage. Her interdisciplinary work draws on public health and the social sciences, combining qualitative, quantitative and mixed-methods approaches to examine primary health care organisation, workforce policy and health system change.
Recent publications
Equity and impact of social prescribing in type 2 diabetes prevention: cross-sectional and cohort study using national primary care data.
Journal article
Calderón-Larrañaga S. et al, (2026), Br J Gen Pract
What can we learn from general practitioners who left Spain? A mixed methods international study
Journal article
Calderón-Larrañaga S. et al, (2024), Human Resources for Health, 22
What does social prescribing look like in practice? A qualitative case study informed by practice theory
Journal article
Calderón-Larrañaga S. et al, (2024), Social Science and Medicine, 343
Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation
Journal article
Calderón-Larrañaga S. et al, (2023), BMC Medicine, 21
Lack of sex-related analysis and reporting in Cochrane Reviews: a cross-sectional study
Journal article
Antequera A. et al, (2022), Systematic Reviews, 11
Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
Journal article
Khalid S. et al, (2022), Osteoporosis International, 33, 1579 - 1589
What does the literature mean by social prescribing? A critical review using discourse analysis
Journal article
Calderón-Larrañaga S. et al, (2022), Sociology of Health and Illness, 44, 848 - 868
Tensions and opportunities in social prescribing. Developing a framework to facilitate its implementation and evaluation in primary care: a realist review
Journal article
Calderón-Larrañaga S. et al, (2021), BJGP Open, 5, 1 - 13
Development and evaluation of a training programme on asset-based community development aimed at general practice trainees: protocol for a mixed-method multilevel and multicentric action research study.
Journal article
Calderón-Larrañaga S. et al, (2021), BMJ Open, 11
Could social prescribing contribute to type 2 diabetes prevention in people at high risk? Protocol for a realist, multilevel, mixed methods review and evaluation
Journal article
Calderón Larrañaga S. et al, (2021), BMJ Open, 11